|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 5/12 |
| (11) | Number of the document | 3087086 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14824322.3 |
| Date of filing the European patent application | 2014-12-18 | |
| (97) | Date of publication of the European application | 2016-11-02 |
| (45) | Date of publication and mention of the grant of the patent | 2018-11-07 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/071310 |
| Date | 2014-12-18 |
| (87) | Number | WO 2015/100144 |
| Date | 2015-07-02 |
| (30) | Number | Date | Country code |
| 201361920427 P | 2013-12-23 | US |
| (72) |
BRINGLEY, Dustin, US
CHAN, Johann, US
FUNG, Peter, US
KEATON, Katie, US
LAPINA, Olga, US
MORRISON, Henry, US
PCION, Dominika, US
|
| (73) |
Gilead Sciences, Inc.,
333 Lakeside Drive, Foster City, CA 94404,
US
|
| (54) | CRYSTALLINE FORMS OF A MACROCYCLIC HCV NS3 INHIBITING TRIPEPTIDE |
| CRYSTALLINE FORMS OF A MACROCYCLIC HCV NS3 INHIBITING TRIPEPTIDE |